GoAI
Get started
Organigram Global Inc. logo

Organigram Global Inc.

OGI

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Previous close

$1.25

+$0.05 · +4.17%

Aug 21, 4:00 PM ET

OGI company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

66

Undervalued

Momentum

19

Strong Down

Sentiment

56

Mixed

Risk resilience

33

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Organigram Global Inc., primarily operating through its subsidiary Organigram Holdings Inc., is a Canadian enterprise specializing in the cultivation, production, and distribution of cannabis and related products. The company serves the medical cannabis market by offering products such as cannabis flowers, oils, and vaporizing devices to both civilian patients and military veterans. For adult recreational consumers, Organigram provides a diverse range of cannabis products, including edibles and concentrates, under popular brands like Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour. Additionally, the company acts as a wholesale supplier, distributing cannabis plant cuttings, dried flowers, proprietary blends, pre-rolled products, and various cannabis derivatives to retailers and other wholesalers within the adult-use recreational sector. Customers can purchase Organigram's offerings through its online platform or via telephone orders. Established in 2013, the company's corporate headquarters are located in Moncton, Canada.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Headquarters
CA
CEO
James H. Yamanaka
Listed since
May 21, 2019
Employees
1,139

Market position

Day range

Current $1.25

52-week range

Current $1.25

Open
$1.21
Previous close
$1.20
Volume
522.49K
0.58× average
Average volume
905.01K
Average daily volume
Market cap
175.97M USD
Beta
1.85
Market reference 1
50-day average
$1.0171
+22.90% above average
200-day average
$1.3544
-7.71% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
341.31M CAD
EV / EBITDA
-23.13×
Earnings yield
-4.93%
Free cash flow yield
-6.83%

Profitability & efficiency

Return on equity
-5.09%
Return on assets
-3.16%
Return on invested capital
-9.32%

Financial health

Current ratio
2.26×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends49%-29%-107%-185%Gross margin, FY2021: -35.87%Gross margin, FY2022: 21.65%Gross margin, FY2023: 23.51%Gross margin, FY2024: 29.73%Gross margin, FY2025: 3.67%Operating margin, FY2021: -115.99%Operating margin, FY2022: -29.59%Operating margin, FY2023: -162.69%Operating margin, FY2024: -22.32%Operating margin, FY2025: -34.07%Net margin, FY2021: -165.11%Net margin, FY2022: -9.80%Net margin, FY2023: -153.80%Net margin, FY2024: -28.43%Net margin, FY2025: -9.55%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 -35.87%. Gross margin FY2022 21.65%. Gross margin FY2023 23.51%. Gross margin FY2024 29.73%. Gross margin FY2025 3.67%. Operating margin FY2021 -115.99%. Operating margin FY2022 -29.59%. Operating margin FY2023 -162.69%. Operating margin FY2024 -22.32%. Operating margin FY2025 -34.07%. Net margin FY2021 -165.11%. Net margin FY2022 -9.80%. Net margin FY2023 -153.80%. Net margin FY2024 -28.43%. Net margin FY2025 -9.55%.

Income trends

Revenue

186.09M CAD+16.42%

Operating income

−63.41M CAD-77.75%

Net income

−17.78M CAD+60.88%
Income trends across reported periods228.98M CAD57.44M CAD−114.09M CAD−285.62M CADRevenue, FY2021: 79.16M CADRevenue, FY2022: 145.81M CADRevenue, FY2023: 149.21M CADRevenue, FY2024: 159.84M CADRevenue, FY2025: 186.09M CADOperating income, FY2021: −91.82M CADOperating income, FY2022: −43.15M CADOperating income, FY2023: −242.74M CADOperating income, FY2024: −35.67M CADOperating income, FY2025: −63.41M CADNet income, FY2021: −130.7M CADNet income, FY2022: −14.28M CADNet income, FY2023: −229.48M CADNet income, FY2024: −45.44M CADNet income, FY2025: −17.78M CADFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 79.16M CAD. Revenue FY2022 145.81M CAD. Revenue FY2023 149.21M CAD. Revenue FY2024 159.84M CAD. Revenue FY2025 186.09M CAD. Operating income FY2021 −91.82M CAD. Operating income FY2022 −43.15M CAD. Operating income FY2023 −242.74M CAD. Operating income FY2024 −35.67M CAD. Operating income FY2025 −63.41M CAD. Net income FY2021 −130.7M CAD. Net income FY2022 −14.28M CAD. Net income FY2023 −229.48M CAD. Net income FY2024 −45.44M CAD. Net income FY2025 −17.78M CAD.
Metric (CAD)FY2025FY2024FY2023FY2022FY2021
Revenue186.09M CAD159.84M CAD149.21M CAD145.81M CAD79.16M CAD
Cost of goods sold179.26M CAD112.32M CAD114.13M CAD114.24M CAD107.56M CAD
Gross profit6.83M CAD47.52M CAD35.07M CAD31.57M CAD−28.4M CAD
Research and development10.95M CAD11.2M CAD12.19M CAD5.96M CAD3.45M CAD
Selling, general, and administrative86.88M CAD68.14M CAD71.68M CAD59.21M CAD46.47M CAD
Operating expenses70.24M CAD83.2M CAD271.48M CAD74.72M CAD63.42M CAD
Interest income825.7K CAD—3.69M CAD——
Interest expense——277.85K CAD429K CAD2.96M CAD
Depreciation and amortization12.91M CAD12.08M CAD23.43M CAD24.91M CAD31.03M CAD
Operating income−63.41M CAD−35.67M CAD−242.74M CAD−43.15M CAD−91.82M CAD
Net income−17.78M CAD−45.44M CAD−229.48M CAD−14.28M CAD−130.7M CAD

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
-0.14
FY2025
Latest fiscal-year revenue
186.09M CAD
FY2025 · +16.42% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend0.13-0.94-2.02-3.09FY21FY22FY23FY24FY25

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend196.79M154.01M111.24M68.47MFY21FY22FY23FY24FY25

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

5 ratings
Strong buy00%
Buy240%
Hold240%
Sell120%
Strong sell00%

OGI peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding OGI

Funds reporting this stock among their holdings, ordered by reported position size.

Amplify Alternative Harvest ETF logoAmplify Alternative Harvest ETFMJ
Market value
2.58M
Weight
2.18%
AUM
118.56M USD
Expense ratio
1.12%
Price / 1D
$26.35+1.62%
AdvisorShares Pure Cannabis ETF logoAdvisorShares Pure Cannabis ETFYOLO
Market value
1.19M
Weight
3.26%
AUM
36.39M USD
Expense ratio
0.91%
Price / 1D
$3.06+3.03%
Amplify Seymour Cannabis ETF logoAmplify Seymour Cannabis ETFCNBS
Market value
151.17K
Weight
0.18%
AUM
82.1M USD
Expense ratio
1.09%
Price / 1D
$28.56+3.19%
Dimensional - International Small Cap ETF logoDimensional - International Small Cap ETFDFIS
Market value
113.91K
Weight
0.00%
AUM
5.91B USD
Expense ratio
0.39%
Price / 1D
$37.545+0.71%

Continue in GoAI

Research OGI

research.disclaimer